STORY SUMMARY
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
This is a brief summary of reporting from CBS News U.S.. Read the original for the full article and context.